Antiplatelet therapy and vascular-access patency

New England Journal of Medicine

Volumn 360, Issue 21, 2009, Pages 2240-2242

  Lok, Charmaine E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE;

ANGIOPLASTY; BLEEDING; BRACHIOBASILIC FISTULA; BRACHIOCEPHALIC FISTULA; CATHETER; ECONOMIC ASPECT; EDITORIAL; FISTULA; GRAFT FAILURE; GRAFT PATENCY; GRAFT SURVIVAL; HEMODIALYSIS; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RADIOCEPHALIC FISTULA; RADIOLOGY; RISK REDUCTION; SURGICAL TECHNIQUE; THROMBOSIS; TREATMENT OUTCOME; VASCULAR ACCESS; VASCULAR PATENCY; DELAYED RELEASE FORMULATION; DRUG COMBINATION; GRAFT OCCLUSION; HUMAN; NOTE; RENAL REPLACEMENT THERAPY;

ASPIRIN; DELAYED-ACTION PREPARATIONS; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; GRAFT OCCLUSION, VASCULAR; HUMANS; PLATELET AGGREGATION INHIBITORS; RENAL DIALYSIS; THROMBOSIS;

EID: 66149147472     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0902841     Document Type: Editorial

References (13)

1. United States Renal Data System. The concise 2008 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, 2008.
2. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996;7:523-535
3. Arora P, Kausz AT, Obrador GT, et al. Hospital utilization among chronic dialysis patients. J Am Soc Nephrol 2000;11:740-746 (Pubitemid 30171883)
4. Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008;299:2164-2171
5. Dixon BS, Beck GJ, Vazquez MA, et al. Effect of dipyridamole plus aspirin on hemodialysis-graft patency. N Engl J Med 2009;360:2191-2201
6. Rehman R, Schmidt RJ, Moss AH. Ethical and legal obligation to avoid long-term tunneled catheter access. Clin J Am Soc Nephrol 2009;4:456-460
7. Lee T, Barker J, Allon M. Comparison of survival of upper arm arteriovenous fistulas and grafts after failed forearm fistula. J Am Soc Nephrol 2007;18:1936-1941 (Pubitemid 46870331)
8. Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 2006;17:3204-3212 (Pubitemid 44707782)
9. Martin DK, Pater JL, Singer PA. Priority-setting decisions for new cancer drugs: a qualitative case study. Lancet 2001;358:1676-1681 (Pubitemid 33124325)
10. Roy-Chaudhury P, Sukhatme VP, Cheung AK. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol 2006;17:1112-1127
11. Himmelfarb J, Couper L. Dipyridamole inhibits PDGF- and bFGF-induced vascular smooth muscle cell proliferation. Kidney Int 1997;52:1671-1677 (Pubitemid 28032074)
12. Kelly BS, Heffelfinger SC, Whiting JF, et al. Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis. Kidney Int 2002;62:2272-2280 (Pubitemid 35366186)
13. Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 2002;62:1109-1124